How TMO's Perfect Beat Rate Collides With Negative Post-Earnings Drift
Thermo Fisher Scientific (TMO) has beaten EPS estimates in every one of the last eight reported quarters, an 8-for-8 (100%) beat rate. The average earnings surprise across those reports is 2.9%. That string of beats would normally point to a bullish earnings setup, yet the price history after the event complicates the picture: the average 5-day move over the five trading days following earnings across those same quarters is -1.64%, and the drift direction is classified as "down."
The four most recent quarters show the beat-to-drift gap in detail. On July 23, 2026, TMO reported $6.03 EPS versus a $5.72 estimate, a 5.4% surprise, but the stock fell 0.71% the next day and gained only 0.78% over the following five sessions. On April 23, 2026, the $5.44 actual against a $5.25 estimate, a 3.6% beat, produced a 0.64% next-day gain and a 2.63% gain over five days. On January 29, 2026, a $6.57 actual versus $6.45 estimate, a 1.9% beat, produced a 2.29% drop the next day and an 8.41% slide over five days. On October 22, 2025, the $5.79 actual versus $5.50 estimate, a 5.3% beat, produced a 0.83% one-day gain but a 1.57% five-day decline. Beats have been consistent; follow-through has been mixed to negative.
Reading Options Flow and Implied Volatility Into the October 28 Report
TMO's next scheduled earnings release is October 28, 2026, before the market open. The published consensus EPS estimate for that report is $6.40. As a Healthcare / Medical - Diagnostics & Research name, TMO's single-stock options must price the gap risk around a company that has beaten in 8 of the last 8 quarters with an average 2.9% surprise. That track record feeds directly into the implied volatility embedded in near-dated calls and puts, especially those expiring closest to the report date.
Current technical context also shapes how options flow reads. TMO's last price is $580.64001, while the 50-day exponential moving average sits at $521.07, leaving the stock roughly 11.4% above that moving average. The RSI reads 70.4, an elevated level. When a stock enters an earnings window technically extended, single-stock option flow can include hedging by long holders alongside directional positions aimed at the post-earnings drift.
What a Disciplined Trader Watches For
A disciplined trader starts with the $6.40 consensus estimate and asks how the reported number compares, not simply whether TMO beats. Beats have occurred in 8 of the last 8 quarters, so the baseline is already a beat. The more important observation is what happens after the headline.
Traders can anchor expectations to the recent one-day reaction range of -2.29% to +0.83% and the five-day range of -8.41% to +2.63%. They can also track whether the -1.64% average five-day drift repeats. Because the RSI is at 70.4 and price is $580.64001 versus a 50-day EMA of $521.07, any earnings result that disappoints relative to the market's real expectation may interact with an extended technical setup. Monitoring order flow, volume at key strikes, and the implied-volatility collapse after the event adds context beyond the headline EPS surprise.
For the full picture of how institutional analysts, quant models, and options desks are positioning around the October 28 report, review the complete institutional verdict on the ticker page.
Frequently Asked Questions
How consistently has TMO beaten EPS estimates?
Over the last eight reported quarters, TMO has beaten the consensus EPS estimate in all eight, a 100% beat rate. The average earnings surprise across those reports is 2.9%.
What has TMO's stock done after recent earnings reports?
The average five-day move following earnings across the last eight quarters is -1.64%. In the four most recent reports, the next-day moves were -0.71%, +0.64%, -2.29%, and +0.83%, while the five-day moves were +0.78%, +2.63%, -8.41%, and -1.57%.
When is TMO's next earnings report and what is expected?
TMO is scheduled to report on October 28, 2026, before the market open. The current consensus EPS estimate is $6.40.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-23 | $6.03 | $5.72 | +5.4% | -0.71% | +0.78% |
| 2026-04-23 | $5.44 | $5.25 | +3.6% | +0.64% | +2.63% |
| 2026-01-29 | $6.57 | $6.45 | +1.9% | -2.29% | -8.41% |
| 2025-10-22 | $5.79 | $5.5 | +5.3% | +0.83% | -1.57% |
| 2025-07-23 | $5.36 | $5.23 | +2.5% | - | - |
| 2025-04-23 | $5.15 | $5.1 | +1% | - | - |
Previous TMO editions
Get the institutional verdict on TMO
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the TMO verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.